Healthcare -
Biotechnology - NYSE - US
$ 7.58
-4.37 %
$ 444 M
Market Cap
-0.81
P/E
DNA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities DNA - Ginkgo Bioworks Holdings, Inc.
-62.2 M
LAST VALUE
3.90%
2 YEAR CAGR
3.56%
5 YEAR CAGR
0.00%
10 YEAR CAGR